Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1920 1
1945 1
1947 1
1949 1
1950 2
1958 1
1959 1
1964 1
1966 3
1973 1
1974 2
1975 1
1976 2
1977 2
1978 2
1979 1
1980 3
1981 2
1982 1
1983 1
1985 2
1986 4
1987 4
1989 5
1991 1
1993 3
1998 1
1999 3
2000 3
2002 1
2003 1
2004 1
2006 4
2007 3
2008 1
2009 1
2011 2
2012 4
2013 5
2014 4
2015 8
2016 6
2017 13
2018 12
2019 7
2020 4
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 23752747

130 results
Results by year
Filters applied: . Clear all
Page 1
Particulate matter in injectable drug products.
Langille SE. Langille SE. PDA J Pharm Sci Technol. 2013 May-Jun;67(3):186-200. doi: 10.5731/pdajpst.2013.00922. PDA J Pharm Sci Technol. 2013. PMID: 23752747
Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations.
Anger S, Begat C, Crnko V, Fantozzi G, Farach W, Fitzpatrick S, Gallagher B, Huelsmann S, Kinsey P, Langlade V, Lefevre G, Legendre E, McLean K, Miller J, Patel R, Perry A, Soukiassian H, Stanton A, Streich D, Timmons C, Vaneylen D, van Hoose T, Wildling L, Windover M. Anger S, et al. PDA J Pharm Sci Technol. 2019 Nov-Dec;73(6):635-647. doi: 10.5731/pdajpst.2019.010645. Epub 2019 Aug 16. PDA J Pharm Sci Technol. 2019. PMID: 31420504
Achieving "Zero" Defects for Visible Particles in Injectables.
Johns J, Golfetto P, Bush T, Fantozzi G, Shabushnig J, Perry A, Degrazio F, Streich D, Miller J, Soukiassian H, Stanton A, Watson R. Johns J, et al. PDA J Pharm Sci Technol. 2018 Nov-Dec;72(6):640-650. doi: 10.5731/pdajpst.2018.009027. Epub 2018 Sep 19. PDA J Pharm Sci Technol. 2018. PMID: 30232141
130 results